Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in GRCE held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Cerity Partners LLC | 849K | $3.9M | +100.8% | 5.487% | 0.01% |
| 2 | Eversept Partners, LP | 757K | $3.5M | β | 4.889% | 0.23% |
| 3 | Nantahala Capital Management, LLC | 728K | $3.4M | -38.2% | 4.706% | 0.17% |
| 4 | BANK OF AMERICA CORP /DE/ | 495K | $2.3M | +0.0% | 3.197% | 0.00% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 402K | $1.9M | β | 2.596% | 0.00% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 244K | $1.1M | +87.9% | 1.576% | 0.00% |
| 7 | JANE STREET GROUP, LLC | 167K | $774K | β | 1.080% | 0.01% |
| 8 | CITADEL ADVISORS LLC | 99K | $457K | +133.4% | 0.638% | 0.00% |
| 9 | MARSHALL WACE, LLP | 91K | $423K | β | 0.591% | 0.00% |
| 10 | Connective Capital Management, LLC | 85K | $391K | β | 0.546% | 0.32% |
| 11 | Quadrature Capital Ltd | 67K | $309K | β | 0.432% | 0.00% |
| 12 | XTX Topco Ltd | 63K | $292K | +108.5% | 0.408% | 0.01% |
| 13 | Birchview Capital, LP | 50K | $232K | β | 0.323% | 0.13% |
| 14 | Diametric Capital, LP | 40K | $184K | β | 0.257% | 0.05% |
| 15 | Pale Fire Capital SE | 38K | $175K | β | 0.244% | 0.02% |
| 16 | UBS Group AG | 26K | $122K | β | 0.170% | 0.00% |
| 17 | KESTRA PRIVATE WEALTH SERVICES, LLC | 13K | $60K | β | 0.084% | 0.00% |
| 18 | PRELUDE CAPITAL MANAGEMENT, LLC | 10K | $47K | β | 0.065% | 0.00% |
| 19 | OPPENHEIMER & CO INC | 10K | $46K | β | 0.065% | 0.00% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 9K | $41K | β | 0.056% | 0.00% |
| 21 | BNP PARIBAS ARBITRAGE, SA | 7K | $33K | +1083.3% | 0.046% | 0.00% |
| 22 | GROUP ONE TRADING, L.P. | 5K | $23K | β | 0.032% | 0.00% |
| 23 | MORGAN STANLEY | 5K | $21K | -82.1% | 0.029% | 0.00% |
| 24 | NATIONAL BANK OF CANADA /FI/ | 3K | $13K | 0.0% | 0.018% | 0.00% |
| 25 | WELLS FARGO & COMPANY/MN | 2K | $8K | β | 0.012% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in GRCE β a direct measure of their conviction.
Filings activity in GRCE during Q1 2026, grouped by how each filer changed its position.
7 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 34 | +55% | 58.00% | +14.09 pp | $20M | +32% |
| Q4 2025 | 22 | +10% | 43.91% | +11.50 pp | $15M | +35% |
| Q3 2025 | 20 | 4.8% | 32.41% | 0.91 pp | $11M | 2.7% |
| Q2 2025 | 21 | +17% | 33.32% | +6.39 pp | $11M | +24% |
| Q1 2025 | 18 | +13% | 26.93% | +3.91 pp | $9M | +17% |
| Q4 2024 | 16 | +1500% | 23.02% | +14.56 pp | $8M | +172% |
| Q3 2024 | 1 | β | 8.46% | β | $3M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying GRCE stock.
Based on Q1 2026 13F filings, institutional ownership of Grace Therapeutics, Inc. stands at 58.0%, held across 34 reporting institutions.
Cerity Partners LLC is the largest reported institutional holder of GRCE, with approximately 849,055 shares worth $0.00B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of GRCE, including RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for GRCE is 79 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
18 institutions opened new positions in GRCE during Q1 2026, while 6 fully exited. 12 added to existing positions and 4 trimmed.
GRCE institutional ownership rose by 14.09 percentage points quarter-over-quarter, with a net change of +12 holders.
The top 10 institutions account for 91.8% of all reported 13F value in GRCE, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Grace Therapeutics, Inc. (GRCE) Institutional Ownership